These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

595 related items for PubMed ID: 8049255

  • 1. Cloning and expression of a complementary DNA encoding the bovine receptor for pituitary adenylate cyclase-activating polypeptide (PACAP).
    Miyamoto Y, Habata Y, Ohtaki T, Masuda Y, Ogi K, Onda H, Fujino M.
    Biochim Biophys Acta; 1994 Aug 02; 1218(3):297-307. PubMed ID: 8049255
    [Abstract] [Full Text] [Related]

  • 2. Molecular cloning and functional expression of a cDNA encoding a human pituitary adenylate cyclase activating polypeptide receptor.
    Ogi K, Miyamoto Y, Masuda Y, Habata Y, Hosoya M, Ohtaki T, Masuo Y, Onda H, Fujino M.
    Biochem Biophys Res Commun; 1993 Nov 15; 196(3):1511-21. PubMed ID: 7902709
    [Abstract] [Full Text] [Related]

  • 3. Hypophysiotropic action of pituitary adenylate cyclase-activating polypeptide (PACAP) in the goldfish: immunohistochemical demonstration of PACAP in the pituitary, PACAP stimulation of growth hormone release from pituitary cells, and molecular cloning of pituitary type I PACAP receptor.
    Wong AO, Leung MY, Shea WL, Tse LY, Chang JP, Chow BK.
    Endocrinology; 1998 Aug 15; 139(8):3465-79. PubMed ID: 9681497
    [Abstract] [Full Text] [Related]

  • 4. Specific antibody recognition of rat pituitary adenylate cyclase activating polypeptide receptors.
    Li M, Shioda S, Somogyvári-Vigh A, Onda H, Arimura A.
    Endocrine; 1997 Oct 15; 7(2):183-90. PubMed ID: 9549044
    [Abstract] [Full Text] [Related]

  • 5. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
    Alexandre D, Anouar Y, Jegou S, Fournier A, Vaudry H.
    Endocrinology; 1999 Mar 15; 140(3):1285-93. PubMed ID: 10067855
    [Abstract] [Full Text] [Related]

  • 6. cDNA cloning of a mouse pituitary adenylate cyclase-activating polypeptide receptor.
    Hashimoto H, Yamamoto K, Hagigara N, Ogawa N, Nishino A, Aino H, Nogi H, Imanishi K, Matsuda T, Baba A.
    Biochim Biophys Acta; 1996 Jun 11; 1281(2):129-33. PubMed ID: 8664310
    [Abstract] [Full Text] [Related]

  • 7. Tissue-specific and developmental expression of pituitary adenylate cyclase-activating polypeptide (PACAP) receptors in rat brain.
    D'Agata V, Cavallaro S, Stivala F, Canonico PL.
    Eur J Neurosci; 1996 Feb 11; 8(2):310-8. PubMed ID: 8714702
    [Abstract] [Full Text] [Related]

  • 8. Characterization and messenger ribonucleic acid distribution of a cloned pituitary adenylate cyclase-activating polypeptide type I receptor in the frog Xenopus laevis brain.
    Hu Z, Lelievre V, Chao A, Zhou X, Waschek JA.
    Endocrinology; 2000 Feb 11; 141(2):657-65. PubMed ID: 10650947
    [Abstract] [Full Text] [Related]

  • 9. Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP-receptor type 1 expression in rat and human placenta.
    Scaldaferri ML, Modesti A, Palumbo C, Ulisse S, Fabbri A, Piccione E, Frajese G, Moretti C.
    Endocrinology; 2000 Mar 11; 141(3):1158-67. PubMed ID: 10698193
    [Abstract] [Full Text] [Related]

  • 10. Properties of the pituitary adenylate cyclase-activating polypeptide I and II receptors, vasoactive intestinal peptide1, and chimeric amino-terminal pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal peptide1 receptors: evidence for multiple receptor states.
    Van Rampelbergh J, Gourlet P, De Neef P, Robberecht P, Waelbroeck M.
    Mol Pharmacol; 1996 Dec 11; 50(6):1596-604. PubMed ID: 8967982
    [Abstract] [Full Text] [Related]

  • 11. Molecular cloning and functional expression of rat cDNAs encoding the receptor for pituitary adenylate cyclase activating polypeptide (PACAP).
    Hosoya M, Onda H, Ogi K, Masuda Y, Miyamoto Y, Ohtaki T, Okazaki H, Arimura A, Fujino M.
    Biochem Biophys Res Commun; 1993 Jul 15; 194(1):133-43. PubMed ID: 7687425
    [Abstract] [Full Text] [Related]

  • 12. Differentiation induces pituitary adenylate cyclase-activating polypeptide receptor expression in PC-12 cells.
    Cavallaro S, D'Agata V, Guardabasso V, Travali S, Stivala F, Canonico PL.
    Mol Pharmacol; 1995 Jul 15; 48(1):56-62. PubMed ID: 7623775
    [Abstract] [Full Text] [Related]

  • 13. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
    Solano RM, Carmena MJ, Carrero I, Cavallaro S, Roman F, Hueso C, Travali S, Lopez-Fraile N, Guijarro LG, Prieto JC.
    Endocrinology; 1996 Jul 15; 137(7):2815-22. PubMed ID: 8770902
    [Abstract] [Full Text] [Related]

  • 14. Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP synthesis and characterization by 125I-VIP binding.
    Zawilska JB, Dejda A, Niewiadomski P, Gozes I, Nowak JZ.
    J Mol Neurosci; 2005 Jul 15; 25(3):215-24. PubMed ID: 15800375
    [Abstract] [Full Text] [Related]

  • 15. Cloning and functional characterization of a third pituitary adenylate cyclase-activating polypeptide receptor subtype expressed in insulin-secreting cells.
    Inagaki N, Yoshida H, Mizuta M, Mizuno N, Fujii Y, Gonoi T, Miyazaki J, Seino S.
    Proc Natl Acad Sci U S A; 1994 Mar 29; 91(7):2679-83. PubMed ID: 8146174
    [Abstract] [Full Text] [Related]

  • 16. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
    Zawilska JB, Niewiadomski P, Nowak JZ.
    Gen Comp Endocrinol; 2004 Jun 29; 137(2):187-95. PubMed ID: 15158130
    [Abstract] [Full Text] [Related]

  • 17. Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide stimulate two signaling pathways in CHO cells stably transfected with the selective type I PACAP receptor.
    Delporte C, Poloczek P, de Neef P, Vertongen P, Ciccarelli E, Svoboda M, Herchuelz A, Winand J, Robberecht P.
    Mol Cell Endocrinol; 1995 Jan 29; 107(1):71-6. PubMed ID: 7796937
    [Abstract] [Full Text] [Related]

  • 18. Differential expression of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes in clonal pituitary somatotrophs and gonadotrophs.
    Rawlings SR, Piuz I, Schlegel W, Bockaert J, Journot L.
    Endocrinology; 1995 May 29; 136(5):2088-98. PubMed ID: 7720658
    [Abstract] [Full Text] [Related]

  • 19. Enhanced production of pituitary adenylate-cyclase-activating polypeptide by 1, N6-dibutyryladenosine 3',5'-monophosphate, phorbol 12-myristate 13-acetate and by the polypeptide itself in human neuroblastoma cells, IMR-32.
    Suzuki N, Harada M, Hosoya M, Fujino M.
    Eur J Biochem; 1994 Jul 01; 223(1):147-53. PubMed ID: 7913440
    [Abstract] [Full Text] [Related]

  • 20. The pituitary adenylate cyclase activating polypeptide (PACAP I) and VIP (PACAP II VIP1) receptors stimulate inositol phosphate synthesis in transfected CHO cells through interaction with different G proteins.
    Van Rampelbergh J, Poloczek P, Françoys I, Delporte C, Winand J, Robberecht P, Waelbroeck M.
    Biochim Biophys Acta; 1997 Jun 27; 1357(2):249-55. PubMed ID: 9223629
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.